tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ENLV Stock Latest News

Enlivex’s Strategic Advancements and Patent Protection Drive Buy Rating for Osteoarthritis Treatment
RatingsEnlivex’s Strategic Advancements and Patent Protection Drive Buy Rating for Osteoarthritis Treatment
6d ago
ENLV
Enlivex Announces Positive Phase IIa Results for Allocetra™ in Knee Osteoarthritis
PremiumCompany Announcements
Enlivex Announces Positive Phase IIa Results for Allocetra™ in Knee Osteoarthritis
7d ago
6K
ENLV
Enlivex Therapeutics CEO issues letter to shareholders on Allocetra results
PremiumThe Fly
Enlivex Therapeutics CEO issues letter to shareholders on Allocetra results
7d ago
ENLV
Enlivex Secures Israeli Patent for Osteoarthritis Treatment
PremiumCompany Announcements
Enlivex Secures Israeli Patent for Osteoarthritis Treatment
9d ago
6K
ENLV
Enlivex Therapeutics announces issuance of Israeli patent for Allocetra
PremiumThe Fly
Enlivex Therapeutics announces issuance of Israeli patent for Allocetra
9d ago
ENLV
Promising Potential of Enlivex’s Allocetra in Osteoarthritis: Buy Rating with $7 Price Target
PremiumRatingsPromising Potential of Enlivex’s Allocetra in Osteoarthritis: Buy Rating with $7 Price Target
16d ago
ENLV
Enlivex Reports Financial Results for Mid-2025
Premium
Company Announcements
Enlivex Reports Financial Results for Mid-2025
20d ago
6K
ENLV
Enlivex’s Allocetra: A New Hope for Psoriatic Arthritis?
Premium
Company Announcements
Enlivex’s Allocetra: A New Hope for Psoriatic Arthritis?
29d ago
ENLV
Enlivex Therapeutics’ Phase 2 Study on Allocetra-OTS for Sepsis: Key Insights for Investors
PremiumCompany Announcements
Enlivex Therapeutics’ Phase 2 Study on Allocetra-OTS for Sepsis: Key Insights for Investors
29d ago
ENLV
Enlivex Therapeutics’ Phase 2 Study on Allocetra-OTS: A Promising Update for Sepsis Treatment
PremiumCompany Announcements
Enlivex Therapeutics’ Phase 2 Study on Allocetra-OTS: A Promising Update for Sepsis Treatment
30d ago
ENLV
Enlivex Therapeutics Advances Psoriatic Arthritis Treatment with Allocetra Study
PremiumCompany Announcements
Enlivex Therapeutics Advances Psoriatic Arthritis Treatment with Allocetra Study
30d ago
ENLV
Enlivex Announces Promising Phase IIa Results for Allocetra in Knee Osteoarthritis
PremiumCompany Announcements
Enlivex Announces Promising Phase IIa Results for Allocetra in Knee Osteoarthritis
1M ago
6K
ENLV
Enlivex Reports Positive Phase IIa Trial Results for Allocetra™ in Knee Osteoarthritis
PremiumCompany AnnouncementsEnlivex Reports Positive Phase IIa Trial Results for Allocetra™ in Knee Osteoarthritis
1M ago
6K
ENLV
Enlivex Therapeutics announces topline data from Phase I/II trial of Allocetra
Premium
The Fly
Enlivex Therapeutics announces topline data from Phase I/II trial of Allocetra
1M ago
ENLV
Enlivex to Present Key Results from Osteoarthritis Trial
Premium
Company Announcements
Enlivex to Present Key Results from Osteoarthritis Trial
1M ago
6K
ENLV
Enlivex to present 3-month data from Phase IIa osteoarthritis trial
PremiumThe Fly
Enlivex to present 3-month data from Phase IIa osteoarthritis trial
1M ago
ENLV
Enlivex Therapeutics’ Promising Study on Allocetra for Knee Osteoarthritis
PremiumCompany Announcements
Enlivex Therapeutics’ Promising Study on Allocetra for Knee Osteoarthritis
1M ago
ENLV
Enlivex Completes Key Phase II Trial Milestone for Knee Osteoarthritis Treatment
PremiumCompany Announcements
Enlivex Completes Key Phase II Trial Milestone for Knee Osteoarthritis Treatment
2M ago
6K
ENLV
Enlivex reaffirms August 18 as target date for Phase II data announcement
PremiumThe Fly
Enlivex reaffirms August 18 as target date for Phase II data announcement
2M ago
ENLV
Enlivex Therapeutics to present clinical data of Allocetra in osteoarthritis
PremiumThe FlyEnlivex Therapeutics to present clinical data of Allocetra in osteoarthritis
3M ago
ENLV
Enlivex Reports Q1 2025 Financial Results with Reduced Loss
Premium
Company Announcements
Enlivex Reports Q1 2025 Financial Results with Reduced Loss
4M ago
6K
ENLV
Enlivex Therapeutics selected to present at Israeli BioMed 2025 conference
Premium
The Fly
Enlivex Therapeutics selected to present at Israeli BioMed 2025 conference
4M ago
ENLV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >